Amedica Corporation, a spinal
and reconstructive medical device manufacturer, announced today it has
received 510(k) clearance from the U.S. Food and Drug Administration to
legally market a second generation family of cervical and lumbar interbody
fusion devices (IBF) manufactured with the company's proprietary Silicon
Nitride biomaterial. The product portfolio expansion offers design
enhancements including a threaded insertion feature, additional footprints,
and design elements that will allow surgeons to perform minimally invasive and
lumbar lateral interbody fusion (LLIF) approaches.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in